Plant-forward diets and the social cultural milieu

Humanity’s window for climate action is closing rapidly (Tollefson, 2022). Given the ecological footprint associated with animal husbandry, scholars and non-governmental organisations have called for a transition to a more sustainable food system: an increased focused on plant-derived proteins (Clark et al., 2022; Willett et al., 2019). Such a transformation will require the collaboration of many actors both in- and outside of academia (e.g., social scientists, food technologists, businesspeople, and advocates). The field of Psychology has a unique role to play in studying human behaviour and cognition as it pertains to societal eating norms and the acceptance of plant-forward diets. Research of this kind has demonstrated that decisions to forgo animal-derived foods constitute a social eating norm violation and as such ought to be understood against the wider context in which they exist. Indeed, food-related decision-making occurs at various levels of society and food systems – including at the micro- (e.g., an individual’s own attitudes, motivations, and capabilities), meso- (e.g., family roles, relational dynamics) and distal-level (e.g., societal, and cultural norms around food; Boulet et al., 2021). Yet, to the authors knowledge, there is limited psychological literature that has considered these processes as they relate to plant-forward diets, specifically. Accordingly, the current thesis presents a rich exploration into the influence that one’s social-cultural milieu has on their food-related cognitions and decision making as they pertain to plant-forward eating. Study 1 employed smartphone-based experience sampling methodology and engaged in a micro-level analysis, investigating an individual’s commitment to reducing their meat consumption as influences by the experience of social support. In summary, we were unable to demonstrate the facilitative effects of social support in study 1. The results of this study highlighted the need to differentiate between types of social support (incl. structural, functional, and enacted means of support) and prompted a progression of our research focus: a move from studying food decision-making at the micro- to the meso-level. Study 2 and 3 employed a mix of survey and experience-sampling methodology with an elevated focus on the meso-level (i.e., the household), where we considered the influence of one’s primary social units (i.e., family members and romantic partners) on decisions pertaining to plant-forward diets. Here we demonstrated that micro-level food decision-making takes place within the broader context of intra-family negotiations and is subject to the established leadership style and emotional connection of the relationship. Finally, study 4 and 5 considered the intergroup and social-cultural context of plant-forward diets at the distal-level. Specifically, we employed a mix of survey methodology, text, and behaviour analytics to investigate the collective identity and ideological motivations of individuals actively engaged in overt antagonism or opposition towards vegan ideology. Together, this body of research advances current knowledge of the social and cultural milieu of plant-forward by demonstrating how decisions around plant-forward diets depend upon the relational climate of cohabiting units and highlighting the importance of identity and inter-group processes in the wider societal debate about sustainable diets

A Retrospective Descriptive Study of Stat TPN Orders in the Neonatal Intensive Care Unit

BACKGROUND: Total parenteral nutrition (TPN) is used in the Neonatal Intensive Care Unit (NICU) to meet metabolic demand and provide growth. To prevent harm from critical laboratory abnormalities, stat TPNs can be ordered urgently to change the content of infusing TPN. Each stat order breaks the daily cycle and often leads to additional stat orders. Limited supplies of ingredients brought focus on our liberal stat TPN policy and how to reduce the number of stat TPNs safely. The purpose of this project was to evaluate biochemical abnormalities associated with stat TPNs and identify leverage points to reduce stat TPNs in NICU patients. METHODS: Data from 1/1/10 to 6/30/10 were abstracted from Meditech, NeoData, and patient charts for NICU stat TPN orders. Demographics, laboratory results (sodium, potassium, calcium, and glucose), and key variables were gathered and critical laboratory values were identified. RESULTS: A total of 112 patients had evaluable orders for 255 stat TPNs. Mean gestation was 31 weeks (SD = 5) and birth weight was 1.744 kg (SD = 0.993). Seven (3%) were never infused. Twenty (12.6%) of first stat TPNs were from patients taking nothing by mouth. Eighty-eight of first stat TPNs had no critical labs (55% of initial stat TPNs). Of follow-up stat orders, 43% (38/89) followed unnecessary initial stat TPNs. Of the 55 abnormalities that generated the initial stat TPNs, 44 (80%) corrected. CONCLUSIONS: Fifty-two percent of stat TPNs could not be justified. For situations that were justified, 20% of laboratory abnormalities from initial stat TPNs were not corrected. These data provide an opportunity to reduce unnecessary costs and save limited resources

Engineering Dynamical Phase Diagrams with Driven Lattices in Spinor Gases

We experimentally demonstrate that well-designed driven lattices are versatile tools to simultaneously tune multiple key parameters (namely spin-dependent interactions, spinor phase, and Zeeman energy) for manipulating phase diagrams of spinor gases with negligible heating and atom losses. This opens a new avenue for studying dynamical phase transitions in engineered Hamiltonians. The driven lattice creates additional separatrices in phase space at driving-frequency-determined locations, with progressively narrower separatrices at higher Zeeman energies due to modulation-induced higher harmonics. The vastly expanded range of magnetic fields at which significant spin dynamics occur and improved sensitivities at higher harmonics represent a step towards quantum sensing with ultracold gases

Testing the Impact of Prebiotics on Anxiety-like Behaviors in Aged Male Rats

The composition of gut microbiota has direct impacts on neural structure, neurochemistry, and behavior. Specifically, the gut microbiota has been shown to modulate anxiety-like behaviors. In addition, administering prebiotics, compounds that promote the growth of commensal bacteria, has been demonstrated to reduce anxiety and anxiety-related behaviors. However, this effect has yet to be tested in older animals despite anxiety being implicated as a most common disorder in adult populations. Therefore, this study seeks to fill this knowledge gap by investigating the link between prebiotic interventions and anxiety-like behaviors in aged populations. It was hypothesized that older rats treated with the prebiotic fructooligosaccharide (FOS) would display an increase in exploratory behaviors, correlating to a decrease in anxiety, compared to the controls. Behavioral assays such as the open field test (OFT), elevated plus maze (EPM), and a social anxiety (SA) test were conducted. Results demonstrate moderate evidence that rats administered FOS had increased exploration in the center zone of the OFT. This finding suggests that FOS helps to modulate behavior in aged animals. With moderate evidence for increased exploration as evidence for decreased anxiety in FOS treated animals, this study provides a platform for further investigation of the role of modulating gut microbiota in older animals. Investigating the effects of senescence versus prebiotic treatment of the rats in this cohort was dampened by the limitations of the precedent of behavioral assays utilized on smaller, younger animals. As a result, this study calls for a widening of behavioral assay parameters to allow for effective data collection in an aging population

Presentación

A reaction between imines and anhydrides has been developed with chiral disubstituted anhydrides and chiral imines. The synthesis of highly substituted γ-lactams with three stereogenic centers, including one quaternary center, proceeds at room temperature in high yield and with high diastereoselectivity in most cases. Enantiomerically pure alkyl-substituted anhydrides proceed with no epimerization, thus providing access to enantiomerically pure penta-substituted lactam products

Chemical Inhibition of the Mitochondrial Division Dynamin Reveals Its Role in Bax/Bak-Dependent Mitochondrial Outer Membrane Permeabilization

SummaryMitochondrial fusion and division play important roles in the regulation of apoptosis. Mitochondrial fusion proteins attenuate apoptosis by inhibiting release of cytochrome c from mitochondria, in part by controlling cristae structures. Mitochondrial division promotes apoptosis by an unknown mechanism. We addressed how division proteins regulate apoptosis using inhibitors of mitochondrial division identified in a chemical screen. The most efficacious inhibitor, mdivi-1 (for mitochondrial division inhibitor) attenuates mitochondrial division in yeast and mammalian cells by selectively inhibiting the mitochondrial division dynamin. In cells, mdivi-1 retards apoptosis by inhibiting mitochondrial outer membrane permeabilization. In vitro, mdivi-1 potently blocks Bid-activated Bax/Bak-dependent cytochrome c release from mitochondria. These data indicate the mitochondrial division dynamin directly regulates mitochondrial outer membrane permeabilization independent of Drp1-mediated division. Our findings raise the interesting possibility that mdivi-1 represents a class of therapeutics for stroke, myocardial infarction, and neurodegenerative diseases

Canvass: a crowd-sourced, natural-product screening library for exploring biological space

NCATS thanks Dingyin Tao for assistance with compound characterization. This research was supported by the Intramural Research Program of the National Center for Advancing Translational Sciences, National Institutes of Health (NIH). R.B.A. acknowledges support from NSF (CHE-1665145) and NIH (GM126221). M.K.B. acknowledges support from NIH (5R01GM110131). N.Z.B. thanks support from NIGMS, NIH (R01GM114061). J.K.C. acknowledges support from NSF (CHE-1665331). J.C. acknowledges support from the Fogarty International Center, NIH (TW009872). P.A.C. acknowledges support from the National Cancer Institute (NCI), NIH (R01 CA158275), and the NIH/National Institute of Aging (P01 AG012411). N.K.G. acknowledges support from NSF (CHE-1464898). B.C.G. thanks the support of NSF (RUI: 213569), the Camille and Henry Dreyfus Foundation, and the Arnold and Mabel Beckman Foundation. C.C.H. thanks the start-up funds from the Scripps Institution of Oceanography for support. J.N.J. acknowledges support from NIH (GM 063557, GM 084333). A.D.K. thanks the support from NCI, NIH (P01CA125066). D.G.I.K. acknowledges support from the National Center for Complementary and Integrative Health (1 R01 AT008088) and the Fogarty International Center, NIH (U01 TW00313), and gratefully acknowledges courtesies extended by the Government of Madagascar (Ministere des Eaux et Forets). O.K. thanks NIH (R01GM071779) for financial support. T.J.M. acknowledges support from NIH (GM116952). S.M. acknowledges support from NIH (DA045884-01, DA046487-01, AA026949-01), the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program (W81XWH-17-1-0256), and NCI, NIH, through a Cancer Center Support Grant (P30 CA008748). K.N.M. thanks the California Department of Food and Agriculture Pierce's Disease and Glassy Winged Sharpshooter Board for support. B.T.M. thanks Michael Mullowney for his contribution in the isolation, elucidation, and submission of the compounds in this work. P.N. acknowledges support from NIH (R01 GM111476). L.E.O. acknowledges support from NIH (R01-HL25854, R01-GM30859, R0-1-NS-12389). L.E.B., J.K.S., and J.A.P. thank the NIH (R35 GM-118173, R24 GM-111625) for research support. F.R. thanks the American Lebanese Syrian Associated Charities (ALSAC) for financial support. I.S. thanks the University of Oklahoma Startup funds for support. J.T.S. acknowledges support from ACS PRF (53767-ND1) and NSF (CHE-1414298), and thanks Drs. Kellan N. Lamb and Michael J. Di Maso for their synthetic contribution. B.S. acknowledges support from NIH (CA78747, CA106150, GM114353, GM115575). W.S. acknowledges support from NIGMS, NIH (R15GM116032, P30 GM103450), and thanks the University of Arkansas for startup funds and the Arkansas Biosciences Institute (ABI) for seed money. C.R.J.S. acknowledges support from NIH (R01GM121656). D.S.T. thanks the support of NIH (T32 CA062948-Gudas) and PhRMA Foundation to A.L.V., NIH (P41 GM076267) to D.S.T., and CCSG NIH (P30 CA008748) to C.B. Thompson. R.E.T. acknowledges support from NIGMS, NIH (GM129465). R.J.T. thanks the American Cancer Society (RSG-12-253-01-CDD) and NSF (CHE1361173) for support. D.A.V. thanks the Camille and Henry Dreyfus Foundation, the National Science Foundation (CHE-0353662, CHE-1005253, and CHE-1725142), the Beckman Foundation, the Sherman Fairchild Foundation, the John Stauffer Charitable Trust, and the Christian Scholars Foundation for support. J.W. acknowledges support from the American Cancer Society through the Research Scholar Grant (RSG-13-011-01-CDD). W.M.W.acknowledges support from NIGMS, NIH (GM119426), and NSF (CHE1755698). A.Z. acknowledges support from NSF (CHE-1463819). (Intramural Research Program of the National Center for Advancing Translational Sciences, National Institutes of Health (NIH); CHE-1665145 - NSF; CHE-1665331 - NSF; CHE-1464898 - NSF; RUI: 213569 - NSF; CHE-1414298 - NSF; CHE1361173 - NSF; CHE1755698 - NSF; CHE-1463819 - NSF; GM126221 - NIH; 5R01GM110131 - NIH; GM 063557 - NIH; GM 084333 - NIH; R01GM071779 - NIH; GM116952 - NIH; DA045884-01 - NIH; DA046487-01 - NIH; AA026949-01 - NIH; R01 GM111476 - NIH; R01-HL25854 - NIH; R01-GM30859 - NIH; R0-1-NS-12389 - NIH; R35 GM-118173 - NIH; R24 GM-111625 - NIH; CA78747 - NIH; CA106150 - NIH; GM114353 - NIH; GM115575 - NIH; R01GM121656 - NIH; T32 CA062948-Gudas - NIH; P41 GM076267 - NIH; R01GM114061 - NIGMS, NIH; R15GM116032 - NIGMS, NIH; P30 GM103450 - NIGMS, NIH; GM129465 - NIGMS, NIH; GM119426 - NIGMS, NIH; TW009872 - Fogarty International Center, NIH; U01 TW00313 - Fogarty International Center, NIH; R01 CA158275 - National Cancer Institute (NCI), NIH; P01 AG012411 - NIH/National Institute of Aging; Camille and Henry Dreyfus Foundation; Arnold and Mabel Beckman Foundation; Scripps Institution of Oceanography; P01CA125066 - NCI, NIH; 1 R01 AT008088 - National Center for Complementary and Integrative Health; W81XWH-17-1-0256 - Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program; P30 CA008748 - NCI, NIH, through a Cancer Center Support Grant; California Department of Food and Agriculture Pierce's Disease and Glassy Winged Sharpshooter Board; American Lebanese Syrian Associated Charities (ALSAC); University of Oklahoma Startup funds; 53767-ND1 - ACS PRF; PhRMA Foundation; P30 CA008748 - CCSG NIH; RSG-12-253-01-CDD - American Cancer Society; RSG-13-011-01-CDD - American Cancer Society; CHE-0353662 - National Science Foundation; CHE-1005253 - National Science Foundation; CHE-1725142 - National Science Foundation; Beckman Foundation; Sherman Fairchild Foundation; John Stauffer Charitable Trust; Christian Scholars Foundation)Published versionSupporting documentatio